Carmot Therapeutics, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 23
Rang # Quantité totale PI 63 718
Note d'activité PI 2,3/5.0    27
Rang # Activité PI 29 297

Brevets

Marques

9 0
4 0
10 0
0
 
Dernier brevet 2024 - Synthesis of glp-1r/gipr agonist...
Premier brevet 2009 - Methods of chemotype evolution

Derniers inventions, produits et services

2024 Invention Modulators of g-protein coupled receptors. This disclosure features chemical entities (e.g., a c...
Invention Synthesis of glp-1r/gipr agonists and precursors thereof. The present disclosure provides a novel...
Invention Treatment of adults with overweight or obesity with or without weight-related comorbidities. The ...
Invention Treatment of adults with overweight or obesity with or without weight-related comorbidities. The...
Invention Treatment of diabetes mellitus. The present disclosure provides methods and compositions for tre...
Invention Treatment of diabetes mellitus. The present disclosure provides methods and compositions for trea...
2023 Invention N-heterocylic gpcr receptor agonists, pharmaceutical compositions comprising the same, and method...
2022 Invention Oxazole, oxadiazole, and indole derivatives for the inhibition of usp28. Provided herein are USP...
Invention Oxazole, oxadiazole, and indole derivatives for the inhibition of usp28. Provided herein are USP2...
Invention Modulators of g-protein coupled receptors. This disclosure features chemical entities (e.g., a co...
Invention Benzimidazoyl glp-1 receptor agonists, pharmaceutical compositions comprising the same, and metho...
Invention Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their us...
2019 Invention N-cyano-7-azanorbornane derivatives and uses thereof. The present invention provides a compound o...
2009 Invention Methods of chemotype evolution. Herein is described a method to rapidly screen a large chemical s...